Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

More PDE4 inhibitors described by Byk Gulden

Aug. 20, 1998

TA-270 inhibits the immediate and late asthmatic response and blocks DTH in animal studies

Aug. 19, 1998

SynPhar's HLE inhibitors show unique potential in preventing lung injury

Aug. 18, 1998

Two new series of PDE4 inhibitors reported by Byk Gulden

Aug. 18, 1998

Schering-Plough patents new tachykinin NK1/NK2 antagonists

Aug. 14, 1998

More PDE IVA inhibitors in the pipeline at Kyowa Hakko

Aug. 13, 1998

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

Aug. 12, 1998

Antiinflammatory cytokine modulators described by Amgen

Aug. 12, 1998

Kyowa Hakko discovers PDE IVA inhibitors for a range of potential indications

Aug. 12, 1998

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026